A review of transcranial magnetic stimulation in vascular dementia

Dementia and Geriatric Cognitive Disorders

Volumn 31, Issue 1, 2011, Pages 71-80

  Pennisi, Giovanni ^a   Ferri, Raffaele ^b   Cantone, Mariagiovanna ^a   Lanza, Giuseppe ^a   Pennisi, Manuela ^a   Vinciguerra, Luisa ^a   Malaguarnera, Giulia ^a   Bella, Rita ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b OASI RESEARCH INSTITUTE IRCCS   (Italy)

Author keywords

Transcranial magnetic stimulation; Vascular dementia

Indexed keywords

AGING; ALZHEIMER DISEASE; ARTICLE; BRAIN DAMAGE; CADASIL; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; HUMAN; MOTOR CORTEX; MULTIINFARCT DEMENTIA; NERVE CELL EXCITABILITY; NERVE CELL NETWORK; NEUROTRANSMISSION; PRIORITY JOURNAL; SUBCORTICAL ISCHEMIC VASCULAR DEMENTIA; TRANSCRANIAL MAGNETIC STIMULATION; VASCULAR LESION; WHITE MATTER;

AGED; ALZHEIMER DISEASE; CADASIL; CEREBRAL CORTEX; CLINICAL TRIALS AS TOPIC; DEMENTIA, VASCULAR; HUMANS; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 78651395777     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000322798     Document Type: Article

References (115)

1. Fratiglioni L, Laurer LJ, Andersen K, Breteler MM, Copeland JR, Dartigues JF, Lobo A, Martinez-Lage J, Soininen H, Hofman A: Incidence of dementia and major subtypes in Europe: a collaborative study of population base cohorts. Neurology 2000;54: S10-S15.
2. Lobo A, Launer LJ, Fratiglioni L, Andersen K, Di Carlo A, Breteler MM, Copeland JR, Dartigues JF, Jagger C, Martinez-Lage J, Soininen H, Hofman A, Neurologic Diseases in the Elderly Research Group: Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurology 2000;54: S4-S9.
3. Hachinski V: Vascular dementia: a radical redef inition. Dementia 1994;5:130-132.
4. Bowler JV: The concept of vascular cognitive impairment. J Neurol Sci 2002;203-204:11-15.
5. O'Brien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni L, Bowler JV, Ballard C, DeCarli C, Gorelick PB, Rockwood K, Burns A, Gauthier S, DeKosky ST: Vascular cognitive impairment. Lancet Neurol 2003;2:89-98.
6. Román GC: Vascular dementia may be the most common form of dementia in the elderly. J Neurol Sci 2002;203-204:7-10.
7. Moorhouse P, Rockwood K: Vascular cognitive impairment: current concepts and clinical developments. Lancet Neurol 2008;7:246-255.
8. Román GC, Erkinjuntti T, Wallin A, Pantoni L, Chui HC: Subcortical ischaemic vascular dementia. Lancet Neurol 2002;1:426-436.
9. Román GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hoffman A, Moody DM, O'Brien MD, Yamaguchi T, Grafman J, Drayer BP, Bennett DA, Fisher M, Ogata J, Kokmen E, Bermejo F, Wolf PA, Gorelick PB, Bick KL, Pajeau AK, Bell MA, DeCarli C, Culebras A, Korezyn AD, Bogousslavsky J, Hartmann A, Scheimberg P: Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-260.
10. Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R: Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology 1992;42:473-480.
11. WHO: ICD-10: International Classification of Diseases, ed 10. Geneva, WHO 1992.
12. Snowdon D D A, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR: Brain infarction and the clinical expression of Alzheimer disease: The Nun Study. JAMA 1997;277:813-817.
13. Englund E, Brun A, Persson B: Correlations between histopathologic white matter changes and proton MR relaxation times in dementia. Alzheimer Dis Assoc Disord 1987;1:156-170.
14. Kalaria R: Similarities between Alzheimer's disease and vascular dementia. J Neurol Sci 2002;203-204:29-34.
15. Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson LA, Nilsson L, Persson G, Odén A, Svanborg A: 15-year longitudinal study of blood pressure and dementia. Lancet 1996;347:1141-1145.
16. Ott A, Breteler MM, de Bruyne MC, van Harskamp F, Grobbee DE, Hofman A: Atrial fibrillation and dementia in a populationbased study: The Rotterdam Study. Stroke 1997;28:316-321.
17. Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM: Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology 1999;53:1937-1942.
18. Jick H, Zornberg GL, Jick SS, Seshadri S, Drachman DA: Statins and the risk of dementia. Lancet 2000;356:1627-1631.
19. Roher AE, Esh C, Kokjohn TA, Kalback W, Luehrs DC, Seward JD, Sue LI, Beach TG: Circle of Willis atherosclerosis is a risk factor for sporadic Alzheimer's disease. Arterioscler Thromb Vasc Biol 2003;23:2055-2062.
20. Kalaria RN: Arteriosclerosis, apolipoprotein E, and Alzheimer's disease. Lancet 1997;349:1174-1175.
21. Premkumar DR, Cohen DL, Hedera P, Friedland RP, Kalaria RN: Apolipoprotein E-e4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am J Pathol 1996;148:2083-2095.
22. Perry EK, Gibson PH, Blessed G, Perry RH, Tomlinson BE: Neurotransmitter enzyme abnormalities in senile dementia: choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue. J Neurol Sci 1977;34:247-265.
23. Gottfries CG, Blennow K, Karlsson I, Wallin A: The neurochemistry of vascular dementia. Dementia 1994;5:163-167.
24. Román GC, Royall DR: Executive control function: a rational basis for the diagnosis of vascular dementia. Alzheimer Dis Assoc Disord 1999;13: S69-S80.
25. Hargrave R, Geck LC, Reed B, Mungas D: Affective behavioural disturbances in Alzheimer's disease and ischaemic vascular disease. J Neurol Neurosurg Psychiatry 2000;68:41-46.
26. Groves WC, Brandt J, Steinberg M, Warren A, Rosenblatt A, Baker A, Lyketsos CG: Vascular dementia and Alzheimer's disease: is there a difference? A comparison of symptoms by disease duration. J Neuropsychiatry Clin Neurosci 2000;12:305-315.
27. Pantoni L, Basile AM, Pracucci G, Asplund K, Bogousslavsky J, Chabriat H, Erkinjuntti T, Fazekas F, Ferro JM, Hennerici M, O'Brien J, Scheltens P, Visser MC, Wahlund LO, Waldemar G, Wallin A, Inzitari D: Impact of age-related cerebral white matter changes on the transition to disability - the LADIS study: rationale, design and methodology. Neuroepidemiology 2005;24:51-62.
28. Jokinen H, Kalska H, Ylikoski R, Madureira S, Verdelho A, van der Flier WM, Scheltens P, Barkhof F, Visser MC, Fazekas F, Schmidt R, O'Brien J, Waldemar G, Wallin A, Chabriat H, Pantoni L, Inzitari D, Erkinjuntti T; LADIS group: Longitudinal cognitive decline in subcortical ischemic vascular disease - the LADIS Study. Cerebrovasc Dis 2009;27:384-391.
29. Inzitari D, Pracucci G, Poggesi A, Carlucci G, Barkhof F, Chabriat H, Erkinjuntti T, Fazekas F, Ferro JM, Hennerici M, Langhorne P, O'Brien J, Scheltens P, Visser MC, Wahlund LO, Waldemar G, Wallin A, Pantoni L; LADIS Study Group: Changes in white matter as determinant of global functional decline in older independent outpatients: three-year follow-up of LADIS (leukoaraiosis and disability) study cohort. BMJ 2009;339: b2477.
30. Teodorczuk A, Firbank MJ, Pantoni L, Poggesi A, Erkinjuntti T, Wallin A, Wahlund LO, Scheltens P, Waldemar G, Schrotter G, Ferro JM, Chabriat H, Bazner H, Visser M, Inzitari D, O'Brien JT; LADIS Group: Relationship between baseline white-matter changes and development of late-life depressive symptoms: 3-year results from the LADIS study. Psychol Med 2010;40:603-610.
31. Baezner H, Blahak C, Poggesi A, Pantoni L, Inzitari D, Chabriat H, Erkinjuntti T, Fazekas F, Ferro JM, Langhorne P, O'Brien J, Scheltens P, Visser MC, Wahlund LO, Waldemar G, Wallin A, Hennerici MG; LADIS Study Group: Association of gait and balance disorders with age-related white matter changes: the LADIS study. Neurology 2008;70:935-942.
32. Poggesi A, Pracucci G, Chabriat H, Erkinjuntti T, Fazekas F, Verdelho A, Hennerici M, Langhorne P, O'Brien J, Scheltens P, Visser MC, Crisby M, Waldemar G, Wallin A, Inzitari D, Pantoni L; Leukoaraiosis and DIS-ability Study Group: Urinary complaints in nondisabled elderly people with age-related white matter changes: the Leukoaraiosis and DISability (LADIS) Study. J Am Geriatr Soc 2008;56:1638-1643.
33. Cummings JL: Frontal-subcortical circuits and human behavior. Arch Neurol 1993;50:873-880.
34. Mega MS, Cummings JL: Frontal-subcortical circuits and neuropsychiatric disorders. J Neuropsychiatry Clin Neurosci 1994;6:358-370.
35. McGeer PL, McGeer EG: Neurotransmitters and their receptors in the basal ganglia. Adv Neurol 1993;60:93-101.
36. Di Giovanni G, Di Matteo V, Pierucci M, Esposito E: Serotonin-dopamine interaction: electrophysiological evidence. Prog Brain Res 2008;172:45-71.
37. Morari M, Marti M, Sbrenna S, Fuxe K, Bianchi C, Beani L: Reciprocal dopamineglutamate modulation of release in the basal ganglia. Neurochem Int 1998;33:383-397.
38. Tepper JM, Lee CR: GABAergic control of substantia nigra dopaminergic neurons. Prog Brain Res 2007;160:189-208.
39. Selden NR, Gitelman DR, Salamon-Murayama N, Parrish TB, Mesulam MM: Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain. Brain 1998;121:2249-2257.
40. Swartz RH, Sahlas DJ, Black SE: Strategic involvement of cholinergic pathways and executive dysfunction: does location of white matter signal hyperintensities matter? J Stroke Cerebrovasc Dis 2003;12:29-36.
41. Togashi H, Matsumoto M, Yoshioka M, Hirokami M, Minami M, Saito H: Neurochemical profiles in cerebrospinal fluid of strokeprone spontaneously hypertensive rats. Neurosci Lett 1994;166:117-120.
42. Kimura S, Saito H, Minami M, Togashi H, Nakamura N, Nemoto M, Parvez HS: Pathogenesis of vascular dementia in stroke-prone spontaneously hypertensive rats. Toxicology 2000;153:167-178.
43. Martin-Ruiz C, Court J, Lee M, Piggott M, Johnson M, Ballard C, Kalaria R, Perry R, Perry E: Nicotinic receptors in dementia of Alzheimer, Lewy body and vascular types. Acta Neurol Scand Suppl 2000;176:34-41.
44. Mesulam M, Siddique T, Cohen B: Cholinergic denervation in a pure multi-infarct state: observations on CADASIL. Neurology 2003;60:1183-1185.
45. Keverne JS, Low WC, Ziabreva I, Court JA, Oakley AE, Kalaria RN: Cholinergic neuronal deficits in CADASIL. Stroke 2007;38:188-191.
46. Fein G, Di Sclafani V, Tanabe J, Cardenas V, Weiner MW, Jagust WJ, Reed BR, Norman D, Schuff N, Kusdra L, Greenfield T, Chui H: Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease. Neurology 2000;55:1626-1635.
47. Rapisarda G, Bastings E, de Noordhout AM, Pennisi G, Delwaide PJ: Can motor recovery in stroke patients be predicted by early transcranial magnetic stimulation? Stroke 1996;27:2191-2196.
48. Traversa R, Cicinelli P, Bassi A, Rossini PM, Bernardi G: Mapping of motor cortical reorganization after stroke: a brain stimulation study with focal magnetic pulses. Stroke 1997;28:110-117.
49. Alagona G, Delvaux V, Gérard P, De Pasqua V, Pennisi G, Delwaide PJ, Nicoletti F, Maertens de Noordhout A: Ipsilateral motor responses to focal transcranial magnetic stimulation in healthy subjects and acutestroke patients. Stroke 2001;32:1304-1309.
50. Pennisi G, Alagona G, Rapisarda G, Nicoletti F, Costanzo E, Ferri R, Malaguarnera M, Bella R: Transcranial magnetic stimulation after pure motor stroke. Clin Neurophysiol 2002;113:1536-1543.
51. Cicinelli P, Pasqualetti P, Zaccagnini M, Traversa R, Oliveri M, Rossini PM: Interhemispheric asymmetries of motor cortex excitability in the postacute stroke stage: a pairedpulse transcranial magnetic stimulation study. Stroke 2003;34:2653-2658.
52. Profice P, Pilato F, Dileone M, Ranieri F, Capone F, Musumeci G, A Tonali P, Di Lazzaro V: Use of transcranial magnetic stimulation of the brain in stroke rehabilitation. Expert Rev Neurother 2007;7:249-258.
53. Di Lazzaro V, Profice P, Pilato F, Capone F, Ranieri F, Pasqualetti P, Colosimo C, Pravatà E, Cianfoni A, Dileone M: Motor cortex plasticity predicts recovery in acute stroke. Cereb Cortex 2010;20:1523-1528.
54. Alagona G, Bella R, Ferri R, Carnemolla A, Pappalardo A, Costanzo E, Pennisi G: Transcranial magnetic stimulation in Alzheimer disease: motor cortex excitability and cognitive severity. Neurosci Lett 2001;314:57-60.
55. Pennisi G, Alagona G, Ferri R, Greco S, Santonocito D, Pappalardo A, Bella R: Motor cortex excitability in Alzheimer disease: one-year follow-up study. Neurosci Lett 2002;329:293-296.
56. Di Lazzaro V, Oliviero A, Tonali PA, Marra C, Daniele A, Profice P, Saturno E, Pilato F, Masullo C, Rothwell JC: Noninvasive in vivo assessment of cholinergic cortical circuits in AD using transcranial magnetic stimulation. Neurology 2002;59:392-397.
57. Di Lazzaro V, Oliviero A, Pilato F, Saturno E, Dileone M, Marra C, Daniele A, Ghirlanda S, Gainotti G, Tonali PA: Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer's disease. J Neurol Neurosurg Psychiatry 2004;75:555-559.
58. Inghilleri M, Conte A, Frasca V, Scaldaferri N, Gilio F, Santini M, Fabbrini G, Prencipe M, Berardelli A: Altered response to rTMS in patients with Alzheimer's disease. Clin Neurophysiol 2006;117:103-109.
59. Pierantozzi M, Panella M, Palmieri MG, Koch G, Giordano A, Marciani MG, Bernardi G, Stanzione P, Stefani A: Different TMS patterns of intracortical inhibition in early onset Alzheimer dementia and frontotemporal dementia. Clin Neurophysiol 2004;115:2410-2418.
60. Di Lazzaro V, Pilato F, Dileone M, Saturno E, Profice P, Marra C, Daniele A, Ranieri F, Quaranta D, Gainotti G, Tonali PA: Functional evaluation of cerebral cortex in dementia with Lewy bodies. Neuroimage 2007;37:422-429.
61. Ziemann U, Lonnecker S, Steinhoff BJ: Effects of antiepileptics drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study. Ann Neurol 1996;40:367-378.
62. Chen R, Lozano AM, Ashby P: Mechanism of the silent period following transcranial magnetic stimulation: evidence from epidural recordings. Exp Brain Res 1999;128:539-542.
63. Kujirai T, Caramia MD, Rothwell JC, Day BL, Thompson PD, Ferbert A, Wroe S, Asselman P, Marsden CD: Corticocortical inhibition in human motor cortex. J Physiol 1993;471:501-519.
64. Di Lazzaro V, Oliviero A, Meglio M, Cioni B, Tamburrini G, Tonali P, Rothwell JC: Direct demonstration of the effect of lorazepam on the excitability of the human motor cortex. Clin Neurophysiol 2000;111:794-799.
65. Ziemann U, Chen R, Cohen LG, Hallett M: Dextromethorphan decreases the excitability of the human motor cortex. Neurology 1998;51:1320-1324.
66. Di Lazzaro V, Pilato F, Oliviero A, Dileone M, Saturno E, Mazzone P, Insola A, Profice P, Ranieri F, Capone F, Tonali PA, Rothwell JC: Origin of facilitation of motor-evoked potentials after paired magnetic stimulation: direct recording of epidural activity in conscious humans. J Neurophysiol 2006;96:1765-1771.
67. Tokimura H, Di Lazzaro V, Tokimura Y, Oliviero A, Profice P, Insola A, Mazzone P, Tonali P, Rothwell JC: Short latency inhibition of human hand motor cortex by somatosensory input from the hand. J Physiol 2000;523:503-513.
68. Di Lazzaro V, Oliviero A, Profice P, Pennisi MA, Di Giovanni S, Zito G, Tonali P, Rothwell JC: Muscarinic receptor blockade has differential effects on the excitability of intracortical circuits in the human motor cortex. Exp Brain Res 2000;135:455-461.
69. Di Lazzaro V, Oliviero A, Saturno E, Dileone M, Pilato F, Nardone R, Ranieri F, Musumeci G, Fiorilla T, Tonali P: Effects of lora zepam on short latency afferent inhibition and short latency intracortical inhibition in humans. J Physiol 2005;564:661-668.
70. Chibbaro G, Daniele M, Alagona G, Di Pasquale C, Cannavò M, Rapisarda V, Bella R, Pennisi G: Repetitive transcranial magnetic stimulation in schizophrenic patients reporting auditory hallucinations. Neurosci Lett 2005;383:54-57.
71. Schönfeldt-Lecuona C, Lefaucheur JP, Cardenas-Morales L, Wolf RC, Kammer T, Herwig U: The value of neuronavigated rTMS for the treatment of depression. Neurophysiol Clin 2010;40:37-43.
72. Ziemann U, Hallett M, Cohen LG: Mechanisms of deafferentation-induced plasticity in human motor cor tex. J Neurosci 1998;18:7000-7007.
73. Alagona G, Ferri R, Pennisi G, Carnemolla A, Maci T, Domina E, de Noordhout AM, Bella R: Motor cortex excitability in Alzheimer's disease and in subcortical ischemic vascular dementia. Neurosci Lett 2004;362:95-98.
74. Erkinjuntti T: Diagnosis and management of vascular cognitive impairment and dementia. J Neural Transm Suppl 2002;63:91-109.
75. Rossini PM, Barker AT, Berardelli A, Caramia MD, Caruso G, Cracco RQ, Dimitrijevic MR, Hallett M, Katayama Y, Lücking CH, de Noordhout M, Marsden CD, Murray N M F, Rothwell JC, Swash M, Tomberg C: Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application - Report of an IFCN committee. Electroencephalogr Clin Neurophysiol 1994;91:79-92.
76. Kalaria RN: Comparison between Alzheimer's disease and vascular dementia: implications for treatment. Neurol Res 2003;25:661-664.
77. Won SJ, Kim DY, Gwag BJ: Cellular and molecular pathways of ischemic neuronal death. J Biochem Mol Biol 2002;35:67-86.
78. Riedel G, Platt B, Micheau J: Glutamate receptor function in learning and memory. Behav Brain Res 2003;140:1-47.
79. Szydlowska K, Tymianski M: Calcium, ischemia and excitotoxicity. Cell Calcium 2010;47:122-129.
80. Choi DW: Ischemia-induced neuronal apoptosis. Curr Opin Neurobiol 1996;6:667-672.
81. Román GC, Kalaria RN: Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia. Neurobiol Aging 2006;27:1769-1785.
82. Di Lazzaro V, Pilato F, Dileone M, Profice P, Marra C, Ranieri F, Quaranta D, Gainotti G, Tonali PA: In vivo functional evaluation of central cholinergic circuits in vascular dementia. Clin Neurophysiol 2008;119:2494-2500.
83. Nardone R, Bergmann J, Tezzon F, Ladurner G, Golaszewski S: Cholinergic dysfunction in subcortical ischaemic vascular dementia: a transcranial magnetic stimulation study. J Neural Transm 2008;115:737-743.
84. Manganelli F, Ragno M, Cacchiò G, Iodice V, Trojano L, Silvaggio F, Scarcella M, Grazioli M, Santoro L, Perretti A: Motor cortex cholinergic dysfunction in CADASIL: a transcranial magnetic demonstration. Clin Neurophysiol 2008;119:351-355.
85. Pennisi G, Ferri R, Alagona G, Pennisi M, Malaguarnera G, Motta M, Bella R: Motor cortex hyperexcitability in subcortical ischemic vascular dementia. Arch Gerontol Geriatr 2010. doi:10.1016/j.archger.2010.07. 004.
86. Delvaux V, Alagona G, Gérard P, De Pasqua V, Pennisi G, de Noordhout AM: Post-stroke reorganization of hand motor area: a 1-year prospective follow-up with focal transcranial magnetic stimulation. Clin Neurophysiol 2003;114:1217-1225.
87. Schmidt R, Ropele S, Ferro J, Madureira S, Verdelho A, Petrovic K, Gouw A, van der Flier WM, Enzinger C, Pantoni L, Inzitari D, Erkinjuntti T, Scheltens P, Wahlund LO, Waldemar G, Rostrup E, Wallin A, Barkhof F, Fazekas F; LADIS study group: Diffusionweighted imaging and cognition in the leukoariosis and disability in the elderly study. Stroke 2010;41: e402-e408.
88. Ragno M, Tournier-Lasserve E, Fiori MG, Manca A, Patrosso MC, Ferlini A, Sirocchi G, Trojano L, Chabriat H, Salvi F: An Italian kindred with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Ann Neurol 1995;38:231-236.
89. O'Sullivan M, Jarosz JM, Martin RJ, Deasy N, Powell JF, Markus HS: MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL. Neurology 2001;56:628-634.
90. Everitt BJ, Robbins TW: Central cholinergic systems and cognition. Annu Rev Psychol 1997;48:649-684.
91. De Carvalho M, de Mendonça A, Miranda PC, Garcia C, Luís ML: Magnetic stimulation in Alzheimer's disease. J Neurol 1997;244:304-307.
92. Inghilleri M, Conte A, Frasca V, Scaldaferri N, Gilio F, Santini M, Fabbrini G, Prencipe M, Berardelli A: A ltered resp onse to rTMS in patients with Alzheimer's disease. Clin Neurophysiol 2006;117:103-109.
93. Julkunen P, Jauhiainen AM, Westerén-Punnonen S, Pirinen E, Soininen H, Könönen M, Pääkkönen A, Määttä S, Karhu J: Navigated TMS combined with EEG in mild cognitive impairment and Alzheimer's disease: a pilot study. J Neurosci Methods 2008;172:270-276.
94. Liepert J, Bär KJ, Meske U, Weiller C: Motor cortex disinhibition in Alzheimer's disease. Clin Neurophysiol 2001;112:1436-1441.
95. Martorana A, Stefani A, Palmieri MG, Esposito Z, Bernardi G, Sancesario G, Pierantozzi M: L-dopa modulates motor cortex excitability in Alzheimer's disease patients. J Neural Transm 2008;115:1313-1319.
96. Pepin JL, Bogacz D, de Pasqua V, Delwaide PJ: Motor cortex inhibition is not impaired in patients with Alzheimer's disease: evidence from paired transcranial magnetic stimulation. J Neurol Sci 1999;170:119-123.
97. Di Lazzaro V, Oliviero A, Pilato F, Saturno E, Dileone M, Marra C, Ghirlanda S, Ranieri F, Gainotti G, Tonali P: Neurophysiological predictors of long-term response to AChE inhibitors in AD patients. J Neurol Neurosurg Psychiatry 2005;76:1064-1069.
98. Di Lazzaro V, Pilato F, Dileone M, Saturno E, Oliviero A, Marra C, Daniele A, Ranieri F, Gainotti G, Tonali PA: In vivo cholinergic circuit evaluation in frontotemporal and Alzheimer dementias. Neurology 2006;66:1111-1113.
99. Bütefisch CM, Netz J, Wessling M, Seitz RJ, Hömberg V: Remote changes in cortical excitability a fter stroke. Brain 2003;126:470-481.
100. Ihara M, Tomimoto H, Ishizu K, Mukai T, Yoshida H, Sawamoto N, Inoue M, Doi T, Hashikawa K, Konishi J, Shibasaki H, Fukuyama H: Decrease in cor tical benzod iazepine receptors in symptomatic patients with leukoaraiosis: a positron emission tomography study. Stroke 2004;35:942-947.
101. Orth M, Rothwell JC: The cortical silent period: intrinsic variability and relation to the waveform of the transcranial magnetic stimulation pulse. Clin Neurophysiol 2004;115:1076-1082.
102. Rossini PM, Rossi S, Babiloni C, Polich J: Clinical neurophysiology of aging brain: from normal aging to neurodegeneration. Prog Neurobiol 2007;83:375-400.
103. Oliviero A, Profice P, Tonali PA, Pilato F, Saturno E, Dileone M, Ranieri F, Di Lazzaro V: Effects of aging on motor cortex excitability. Neurosci Res 2006;55:74-77.
104. Rossini PM, Desiato MT, Caramia MD: Age-related changes of motor evoked potentials in healthy humans: non-invasive evaluation of central and peripheral motor tracts excitability and conductivity. Brain Res 1992;593:14-19.
105. Silbert LC, Nelson C, Holman S, Eaton R, Oken BS, Lou JS, Kaye JA: Cortical excitability and age-related volumetric MRI changes. Clin Neurophysiol 2006;117:1029-1036.
106. Peinemann A, Lehner C, Conrad B, Siebner HR: Age-related decrease in paired-pulse intracortical inhibition in the human primary motor cortex. Neurosci Lett 2001;313:33-36.
107. Ferreri F, Pauri F, Pasqualetti P, Fini R, Dal Forno G, Rossini PM: Motor cortex excitability in Alzheimer's disease: a transcranial magnetic stimulation study. Ann Neurol 2003;53:102-108.
108. Reddy H, De Stefano N, Mortilla M, Federico A, Matthews PM: Functional reorganization of motor cortex increases with greater axonal injury from CADASIL. Stroke 2002;33:502-508.
109. Rektorova I, Megova S, Bares M, Rektor I: Cognitive functioning after repetitive transcranial magnetic stimulation in patients with cerebrovascular disease without dementia: a pilot study of seven patients. J Neurol Sci 2005;229-230:157-161.
110. Fabre I, Galinowski A, Oppenheim C, Gallarda T, Meder JF, De Montigny C, Olié JP, Poirier MF: Antidepressant efficacy and cognitive effects of repetitive transcranial magnetic stimulation in vascular depression: an open trial. Int J Geriatr Psychiatry 2004;19:833-842.
111. Jorge RE, Moser DJ, Acion L, Robinson RG: Treatment of vascular depression using repetitive transcranial magnetic stimulation. Arch Gen Psychiatry 2008;65:268-276.
112. Bella R, Pennisi G, Cantone M, Palermo F, Pennisi M, Lanza G, Zappia M, Paolucci S: Clinical presentation and outcome of geriatric depression in subcortical ischemic vascular disease. Gerontology 2010;56:298-302.
113. Wang F, Geng X, Tao HY, Cheng Y: The restoration after repetitive transcranial magnetic stimulation treatment on cognitive ability of vascular dementia rats and its impacts on synaptic plasticity in hippocampal CA1 area. J Mol Neurosci 2010;41:145-155.
114. Sakuma K, Murakami T, Nakashima K: Short latency afferent inhibition is not impaired in mild cognitive impairment. Clin Neurophysiol 2007;118:1460-1463.
115. Olazarán J, Prieto J, Cruz I, Esteban A: Cortical excitability in very mild Alzheimer's disease: a long-term follow-up study. J Neurol 2010; doi: 10.1007/s00415-010-5663-8.